US Stock MarketDetailed Quotes

SKYE SKYE BIOSCIENCE INC

Watchlist
  • 2.250
  • +0.360+19.05%
Close Mar 21 16:00 ET
  • 2.290
  • +0.040+1.78%
Post 19:02 ET
69.69MMarket Cap-3.08P/E (TTM)

SKYE BIOSCIENCE INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-80.89%-25.24M
-112.58%-8.17M
-29.79%-5.26M
-256.13%-7.09M
-15.94%-4.71M
-9.48%-13.95M
21.08%-3.84M
-97.16%-4.05M
31.34%-1.99M
-39.32%-4.06M
Net income from continuing operations
29.43%-26.57M
-120.51%-9.75M
84.37%-3.9M
-153.99%-7.9M
2.86%-5.02M
-93.23%-37.64M
55.32%-4.42M
-697.68%-24.95M
9.00%-3.11M
-69.79%-5.17M
Operating gains losses
-106.28%-1.35M
-3,342.01%-140.43K
-100.34%-72.84K
1,079,300.00%10.79K
-537.52%-1.15M
36,050.49%21.47M
-1,163.16%-4.08K
340,742.44%21.22M
100.01%1
699.55%261.74K
Depreciation and amortization
140.35%298.64K
517.86%175.29K
129.24%66K
-12.17%29.79K
-16.92%27.56K
8.05%124.25K
-10.02%28.37K
-0.06%28.79K
22.52%33.92K
22.97%33.17K
Other non cash items
-330.50%-3.64M
364.39%318.75K
-5,717.08%-4.44M
725.36%250.32K
-83.05%237.21K
-76.86%1.58M
-98.92%68.64K
-52.23%79.08K
-81.05%30.33K
803.69%1.4M
Change In working capital
-460.14%-2.63M
-686.32%-869.44K
282.92%1.08M
-263.36%-1.56M
-78.88%-1.29M
38.40%-469.31K
92.86%-110.57K
-180.19%-592.15K
387.03%952.55K
-389.23%-719.13K
-Change in prepaid assets
-100.97%-7.7K
3,467.84%462.64K
533.41%431.44K
-173.77%-455.5K
-561.66%-446.28K
26,929.69%795.23K
109.42%12.97K
-58.20%68.11K
2,940,300.00%617.48K
442.03%96.67K
-Change in payables and accrued expense
-556.68%-721.44K
-99.69%212
-54.96%-462.33K
-41.99%262.54K
-57.44%-521.87K
-111.52%-109.86K
-71.37%67.39K
-153.76%-298.36K
100.99%452.58K
-438.54%-331.47K
-Change in other current assets
-198.87%-1.46M
157.80%145.66K
15.67%226.95K
-729.03%-1.45M
-49.55%-386.51K
-532.91%-488.79K
-213.29%-252.01K
583.72%196.2K
-984.66%-174.53K
-388.73%-258.44K
-Change in other current liabilities
34.10%-438.79K
-2,549.10%-1.5M
262.18%905.12K
46.94%83.79K
130.22%68.26K
63.53%-665.89K
103.27%61.08K
-1,013.43%-558.1K
521.83%57.02K
-5,151.94%-225.89K
Cash from discontinued investing activities
Operating cash flow
-80.89%-25.24M
-112.58%-8.17M
-29.79%-5.26M
-256.13%-7.09M
-15.94%-4.71M
-9.48%-13.95M
21.08%-3.84M
-97.16%-4.05M
31.34%-1.99M
-39.32%-4.06M
Investing cash flow
Cash flow from continuing investing activities
-103.72%-245.62K
1,388.44%90.41K
-234.71%-1.45M
-32.46K
-79.35%1.14M
26.50%6.6M
-100.12%-7.02K
393.13%1.07M
0
276,758.63%5.53M
Net PPE purchase and sale
-104.45%-245.62K
1,388.44%90.41K
-39,255.35%-1.45M
---32.46K
-79.35%1.14M
19,771.12%5.52M
43.88%-7.02K
64.49%-3.67K
--0
276,758.63%5.53M
Net other investing changes
----
----
----
----
----
-79.46%1.08M
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
-103.72%-245.62K
1,388.44%90.41K
-234.71%-1.45M
---32.46K
-79.35%1.14M
26.50%6.6M
-100.12%-7.02K
393.13%1.07M
--0
276,758.63%5.53M
Financing cash flow
Cash flow from continuing financing activities
408.18%83.56M
124.80%5.62K
0
-1,598.41%-2.1M
189,149.41%85.65M
7,975.36%16.44M
-166.32%-22.65K
18,211.45%16.63M
-34.37%-123.41K
23.55%-45.31K
Net issuance payments of debt
--0
--0
--0
--0
--0
2,336.82%4.71M
-166.32%-22.65K
5,441.25%4.91M
-34.37%-123.41K
26.01%-45.31K
Net common stock issuance
612.03%83.56M
--0
--0
---2.1M
--85.65M
--11.73M
--0
--11.73M
--0
--0
Proceeds from stock option exercised by employees
--5.62K
----
----
----
----
--0
----
----
----
----
Net other financing activities
----
----
----
----
----
---6.03K
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
408.18%83.56M
124.80%5.62K
--0
-1,598.41%-2.1M
189,149.41%85.65M
7,975.36%16.44M
-166.32%-22.65K
18,211.45%16.63M
-34.37%-123.41K
23.55%-45.31K
Net cash flow
Beginning cash position
727.52%10.34M
438.26%76.49M
14,809.68%83.2M
3,357.29%92.42M
727.52%10.34M
-86.10%1.25M
3,283.88%14.21M
-80.98%558.03K
-55.53%2.67M
-86.10%1.25M
Current changes in cash
539.11%58.08M
-108.47%-8.08M
-149.13%-6.71M
-335.98%-9.22M
5,663.79%82.09M
217.43%9.09M
-567.28%-3.87M
642.97%13.65M
31.26%-2.12M
147.85%1.42M
End cash Position
561.88%68.42M
561.88%68.42M
438.26%76.49M
14,809.68%83.2M
3,357.29%92.42M
727.52%10.34M
727.52%10.34M
3,283.88%14.21M
-80.98%558.03K
-55.53%2.67M
Free cash flow
-92.21%-26.84M
-113.49%-8.22M
-67.09%-6.78M
-257.76%-7.13M
-15.96%-4.71M
-9.34%-13.96M
21.14%-3.85M
-96.35%-4.06M
31.42%-1.99M
-39.29%-4.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -80.89%-25.24M-112.58%-8.17M-29.79%-5.26M-256.13%-7.09M-15.94%-4.71M-9.48%-13.95M21.08%-3.84M-97.16%-4.05M31.34%-1.99M-39.32%-4.06M
Net income from continuing operations 29.43%-26.57M-120.51%-9.75M84.37%-3.9M-153.99%-7.9M2.86%-5.02M-93.23%-37.64M55.32%-4.42M-697.68%-24.95M9.00%-3.11M-69.79%-5.17M
Operating gains losses -106.28%-1.35M-3,342.01%-140.43K-100.34%-72.84K1,079,300.00%10.79K-537.52%-1.15M36,050.49%21.47M-1,163.16%-4.08K340,742.44%21.22M100.01%1699.55%261.74K
Depreciation and amortization 140.35%298.64K517.86%175.29K129.24%66K-12.17%29.79K-16.92%27.56K8.05%124.25K-10.02%28.37K-0.06%28.79K22.52%33.92K22.97%33.17K
Other non cash items -330.50%-3.64M364.39%318.75K-5,717.08%-4.44M725.36%250.32K-83.05%237.21K-76.86%1.58M-98.92%68.64K-52.23%79.08K-81.05%30.33K803.69%1.4M
Change In working capital -460.14%-2.63M-686.32%-869.44K282.92%1.08M-263.36%-1.56M-78.88%-1.29M38.40%-469.31K92.86%-110.57K-180.19%-592.15K387.03%952.55K-389.23%-719.13K
-Change in prepaid assets -100.97%-7.7K3,467.84%462.64K533.41%431.44K-173.77%-455.5K-561.66%-446.28K26,929.69%795.23K109.42%12.97K-58.20%68.11K2,940,300.00%617.48K442.03%96.67K
-Change in payables and accrued expense -556.68%-721.44K-99.69%212-54.96%-462.33K-41.99%262.54K-57.44%-521.87K-111.52%-109.86K-71.37%67.39K-153.76%-298.36K100.99%452.58K-438.54%-331.47K
-Change in other current assets -198.87%-1.46M157.80%145.66K15.67%226.95K-729.03%-1.45M-49.55%-386.51K-532.91%-488.79K-213.29%-252.01K583.72%196.2K-984.66%-174.53K-388.73%-258.44K
-Change in other current liabilities 34.10%-438.79K-2,549.10%-1.5M262.18%905.12K46.94%83.79K130.22%68.26K63.53%-665.89K103.27%61.08K-1,013.43%-558.1K521.83%57.02K-5,151.94%-225.89K
Cash from discontinued investing activities
Operating cash flow -80.89%-25.24M-112.58%-8.17M-29.79%-5.26M-256.13%-7.09M-15.94%-4.71M-9.48%-13.95M21.08%-3.84M-97.16%-4.05M31.34%-1.99M-39.32%-4.06M
Investing cash flow
Cash flow from continuing investing activities -103.72%-245.62K1,388.44%90.41K-234.71%-1.45M-32.46K-79.35%1.14M26.50%6.6M-100.12%-7.02K393.13%1.07M0276,758.63%5.53M
Net PPE purchase and sale -104.45%-245.62K1,388.44%90.41K-39,255.35%-1.45M---32.46K-79.35%1.14M19,771.12%5.52M43.88%-7.02K64.49%-3.67K--0276,758.63%5.53M
Net other investing changes ---------------------79.46%1.08M--0------------
Cash from discontinued investing activities
Investing cash flow -103.72%-245.62K1,388.44%90.41K-234.71%-1.45M---32.46K-79.35%1.14M26.50%6.6M-100.12%-7.02K393.13%1.07M--0276,758.63%5.53M
Financing cash flow
Cash flow from continuing financing activities 408.18%83.56M124.80%5.62K0-1,598.41%-2.1M189,149.41%85.65M7,975.36%16.44M-166.32%-22.65K18,211.45%16.63M-34.37%-123.41K23.55%-45.31K
Net issuance payments of debt --0--0--0--0--02,336.82%4.71M-166.32%-22.65K5,441.25%4.91M-34.37%-123.41K26.01%-45.31K
Net common stock issuance 612.03%83.56M--0--0---2.1M--85.65M--11.73M--0--11.73M--0--0
Proceeds from stock option exercised by employees --5.62K------------------0----------------
Net other financing activities -----------------------6.03K--0------------
Cash from discontinued financing activities
Financing cash flow 408.18%83.56M124.80%5.62K--0-1,598.41%-2.1M189,149.41%85.65M7,975.36%16.44M-166.32%-22.65K18,211.45%16.63M-34.37%-123.41K23.55%-45.31K
Net cash flow
Beginning cash position 727.52%10.34M438.26%76.49M14,809.68%83.2M3,357.29%92.42M727.52%10.34M-86.10%1.25M3,283.88%14.21M-80.98%558.03K-55.53%2.67M-86.10%1.25M
Current changes in cash 539.11%58.08M-108.47%-8.08M-149.13%-6.71M-335.98%-9.22M5,663.79%82.09M217.43%9.09M-567.28%-3.87M642.97%13.65M31.26%-2.12M147.85%1.42M
End cash Position 561.88%68.42M561.88%68.42M438.26%76.49M14,809.68%83.2M3,357.29%92.42M727.52%10.34M727.52%10.34M3,283.88%14.21M-80.98%558.03K-55.53%2.67M
Free cash flow -92.21%-26.84M-113.49%-8.22M-67.09%-6.78M-257.76%-7.13M-15.96%-4.71M-9.34%-13.96M21.14%-3.85M-96.35%-4.06M31.42%-1.99M-39.29%-4.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
13.460
New Fortress Energy
NFE
11.170
Cars.com
CARS
11.640
4
Halozyme Therapeutics
HALO
65.160
5
Collegium Pharmaceutical
COLL
30.050
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.